dc.contributor.author | Large, JM | |
dc.contributor.author | Clarke, M | |
dc.contributor.author | Williamson, DM | |
dc.contributor.author | McDonald, E | |
dc.contributor.author | Collins, A | |
dc.date.accessioned | 2016-12-12T13:37:09Z | |
dc.date.issued | 2006-04-04 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000236788600011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
dc.identifier.citation | SYNLETT, 2006, (6), pp. 861 - 864 (4) | |
dc.identifier.issn | 0936-5214 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/322 | |
dc.identifier.eissn | 1437-2096 | |
dc.identifier.doi | 10.1055/s-2006-939050 | |
dc.description.abstract | An efficient, regioselective approach to the synthesis of trisubstituted pyrimidines was developed. Sequential functionalization of com. available polyhalopyrimidines provided the target compds. in moderate to good overall yields. | |
dc.format.extent | 861 - 864 (4) | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | GEORG THIEME VERLAG KG | |
dc.subject | Science & Technology | |
dc.subject | Physical Sciences | |
dc.subject | Chemistry, Organic | |
dc.subject | Chemistry | |
dc.subject | regioselectivity | |
dc.subject | palladium | |
dc.subject | pyrimidine | |
dc.subject | Suzuki | |
dc.subject | cross-coupling | |
dc.subject | CROSS-COUPLING REACTIONS | |
dc.subject | RAPID ANALOG SYNTHESES | |
dc.subject | ARYL CHLORIDES | |
dc.subject | DERIVATIVES | |
dc.subject | CATALYSTS | |
dc.subject | ACIDS | |
dc.title | Synthesis of trisubstituted pyrimidines by regioselective S<sub>N</sub>Ar and Suzuki reactions of polyhalopyrimidines | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2006-03-13 | |
rioxxterms.versionofrecord | 10.1055/s-2006-939050 | |
rioxxterms.licenseref.startdate | 2006-04-04 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | SYNLETT | |
pubs.issue | 6 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 2 | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 2 | |
pubs.publication-status | Published | |
pubs.embargo.terms | Not known | |
icr.researchteam | Medicinal Chemistry 2 | |
dc.contributor.icrauthor | Collins, Ian | |